Status:
COMPLETED
Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath
Lead Sponsor:
Vastra Gotaland Region
Collaborating Sponsors:
Cavis Technologies AB
Conditions:
Coronary Disease
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
In summary, the purpose of the study is to evaluate whether the Wirecath device can be used as a standard pressure wire in a safe and efficient way.
Detailed Description
Simultaneous measurements study (group 1) This group will be recruited and assessed in parallel with recruitment to group 2 at the discretion of the treating physician, based on the resource availabil...
Eligibility Criteria
Inclusion
- Adults (\>18yrs age)
- Informed consent given
- Patients with result from diagnostic angiography
- Indication for coronary pressure assessment
Exclusion
- Patients with known Heparin-Induced Thrombocytopenia (HIT) or allergy to heparin.
- Inability to tolerate Adenosine
- Any condition, e.g. unstable health, which in the opinion of the investigator makes the patient unsuitable for inclusion (Decision documented in inclusion log).
Key Trial Info
Start Date :
February 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04776577
Start Date
February 25 2021
End Date
October 25 2021
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 41345